While ROS-mediated mechanisms of cell death have been previously reported, the present study uniquely identifies PAR-2 as a novel target of OC in CRC, expanding the mechanistic landscape of OC’s antitumor effects. The gene discussed is F2RL1; the disease is colorectal carcinoma.